Clincosm LogoSign in Get a demo

diabetes mellitus, type ii

Showing 26 - 50 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type II Trial (Sitagliptin (MK0431), Placebo/Glipizide 5 mg, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type II
  • Sitagliptin (MK0431)
  • +3 more
  • (no location specified)
Mar 31, 2017

Diabetes, Type II Trial (MK0431, sitagliptin phosphate / Duration of Treatment: 21 Weeks, Comparator: (unspecified) / Duration

Completed
  • Diabetes Mellitus, Type II
  • MK0431, sitagliptin phosphate / Duration of Treatment: 21 Weeks
  • Comparator: placebo (unspecified) / Duration of Treatment: 21 Weeks
  • (no location specified)
Mar 24, 2017

Diabetes Mellitus Type II and Tissue Oxygenation

Terminated
  • Diabetes Mellitus, Type II
    • (no location specified)
    Mar 14, 2017

    Measuring Patient Engagement in Diabetes Care

    Withdrawn
    • Diabetes Mellitus, Type II
      • (no location specified)
      Mar 13, 2017

      Diabetes, Type II Trial in Seoul (triple combination therapy, Stepwise add-on therapy)

      Unknown status
      • Diabetes Mellitus, Type II
      • triple combination therapy
      • Stepwise add-on therapy
      • Seoul, Korea, Republic of
        Korea University Anam Hospital
      Oct 26, 2016

      Diabetes, Type II Trial in Seo-gu (Empagliflozin 25mg, Lobeglitazone 0.5mg, Empagliflozin 25mg/Lobeglitazone 0.5mg)

      Unknown status
      • Diabetes Mellitus, Type II
      • Empagliflozin 25mg
      • +2 more
      • Seo-gu, Busan, Korea, Republic of
        Dong A University Hospital
      Aug 7, 2016

      Diabetes, Type II Trial in Jeonju-si (Duvie Tab. 0.5mg, Duvie Tab. 0.5mg + Januvia Tab. 100mg)

      Completed
      • Diabetes Mellitus, Type II
      • Duvie Tab. 0.5mg
      • Duvie Tab. 0.5mg + Januvia Tab. 100mg
      • Jeonju-si, Korea, Republic of
        Chonbuk National University Hospital
      Jul 6, 2016

      Diabetes, Type II Trial in United States (Placebo, PF-06291874)

      Completed
      Has Results
      • Diabetes Mellitus, Type II
      • Anaheim, California
      • +18 more
      May 10, 2016

      Obesity, Diabetes, Type II, Cardiovascular Disease Trial in New York (Normal Sleep/ Normal Meal, Normal Sleep/ Late Meal, Late

      Completed
      • Obesity
      • +2 more
      • Normal Sleep/ Normal Meal
      • +3 more
      • New York, New York
        New York Nutrition Obesity Research Center
      May 10, 2016

      Glycemic Improvement After Gastrointestinal Surgery

      Completed
      • Diabetes Mellitus, Type II
      • No intervention
      • Seattle, Washington
        University of Washington Medical Center
      Mar 29, 2016

      Diabetes, Type II, Heart Disease, Obesity Trial in Pineville (Microclinic Diabetes Education Program, Control)

      Completed
      • Diabetes Mellitus, Type II
      • +4 more
      • Microclinic Diabetes Education Program
      • Control
      • Pineville, Kentucky
        Bell County Health Department
      Mar 15, 2016

      Diabetes, Type II Trial in Deokjin-gu (CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T)

      Completed
      • Diabetes Mellitus, Type II
      • CKD-395 0.5(Lobeglitazone)/1000(Metformin)mg 1T
      • Deokjin-gu, Jeonju-si, Jeollabuk-do, Korea, Republic of
        Chonbuk National University Hospital
      Feb 5, 2016

      Diabetes, Type II Trial in Jeonju-si (Duvie Tab. 0.5mg, Glucodaun OR Tab. 750mg, CKD-395 0.25/750mg)

      Completed
      • Diabetes Mellitus, Type II
      • Duvie Tab. 0.5mg, Glucodaun OR Tab. 750mg
      • CKD-395 0.25/750mg
      • Jeonju-si, Jeollabuk-do, Korea, Republic of
        Chonbuk National University Hospital
      Jan 5, 2016

      Diabetes, Type II Trial in Jeonju-si (Duvie Tab. 0.5mg, Glucophage XR Tab. 1000mg, CKD-395 0.5/1000mg)

      Completed
      • Diabetes Mellitus, Type II
      • Duvie Tab. 0.5mg, Glucophage XR Tab. 1000mg
      • CKD-395 0.5/1000mg
      • Jeonju-si, Jeollabuk-do, Korea, Republic of
        Chonbuk National University Hospital
      Sep 30, 2015

      Diabetes, Type II, Overweight and Obesity, Hypertension Trial in Doha (Microclinic Social Induction Diabetes and Obesity

      Completed
      • Diabetes Mellitus, Type II
      • +4 more
      • Microclinic Social Induction Diabetes and Obesity Program
      • Doha, Qatar
        Qatar Diabetes Association
      Dec 18, 2014

      Diabetes, Type II Trial in Evansville (LY2189265)

      Completed
      Has Results
      • Diabetes Mellitus, Type II
      • LY2189265
      • Evansville, Indiana
        For additional information regarding investigative sites for thi
      Oct 3, 2014

      Diabetes, Type II Trial in United States (Insulin lispro, Insulin aspart, Recombinant human hyaluronidase PH20)

      Completed
      Has Results
      • Diabetes Mellitus, Type II
      • Insulin lispro
      • +4 more
      • Concord, California
      • +21 more
      Aug 1, 2014

      Diabetes, Type II Trial in Phoenix (Glulisine (Apidra))

      Completed
      • Diabetes Mellitus, Type II
      • Glulisine (Apidra)
      • Phoenix, Arizona
        Phoenix VA Health Care System
      Jul 23, 2014

      Hypertension, Diabetes, Type II Trial in Seoul (Bisoprolol)

      Completed
      Has Results
      • Hypertension
      • Diabetes Mellitus, Type II
      • Seoul, Korea, Republic of
        Seoul St. Mary´s Hospital
      Jun 4, 2014

      Diabetes, Type II, Diabetes, Non Insulin Dependent Trial in Worldwide (Canagliflozin (JNJ-28431754), Sitagliptin, Placebo)

      Completed
      Has Results
      • Diabetes Mellitus, Type II
      • Diabetes Mellitus, Non Insulin Dependent
      • Canagliflozin (JNJ-28431754)
      • +2 more
      • Birmingham, Alabama
      • +84 more
      Jul 15, 2013

      Diabetes, Type II Trial in Boston (Eplerenone, Placebo)

      Unknown status
      • Diabetes Mellitus, Type II
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Feb 15, 2013

      Diabetes, Type II Trial in Seoul (Acarbose/Metformin FDC (BAY81-9783), Acarbose (Glucobay, BAYG5421), Metformin)

      Completed
      • Diabetes Mellitus, Type II
      • Acarbose/Metformin FDC (BAY81-9783)
      • +2 more
      • Seoul, Korea, Republic of
        (unnamed)
      Dec 18, 2012

      Diabetes, Type II Trial in Amman (Microclinic)

      Completed
      • Diabetes Mellitus, Type II
      • Microclinic
      • Amman, Jordan
      • +1 more
      Nov 7, 2012

      Diabetes, Type II, Fatty Liver Trial in United States (INT-747, Placebo)

      Completed
      Has Results
      • Diabetes Mellitus, Type II
      • Fatty Liver
      • Chula Vista, California
      • +3 more
      Apr 17, 2012

      Diabetes, Type II Trial in Worldwide (Placebo, Dutogliptin)

      Terminated
      • Diabetes Mellitus, Type II
      • Birmingham, Alabama
      • +117 more
      Sep 9, 2011